Robin Harper Cowie has been with Biodesix since March 2011 and has served as Chief Financial Officer for Biodesix since April 2017. She brings a depth of experience to the leadership team with a long history with the company and deep expertise in finance, government policy, reimbursement, and operations. Along with this depth of experience, she brings a passion and personal mission to bring access to Biodesix diagnostic testing for every person who needs them.
Robin has been with Biodesix in multiple financial and reimbursement positions since March 2011, serving as Vice President of Finance from February 2016 to April 2017, Vice President of Reimbursement & Health Economics from February 2015 to February 2016, Senior Director of Reimbursement from January 2014 to February 2015, and Director of Reimbursement from March 2011 to January 2014.
Prior to joining Biodesix, Robin held a leadership role in payer and government relations at Precision Therapeutics, Inc. Robin’s background includes corporate finance, managed care and payer relations, government reimbursement and regulatory policy, legal affairs, health economics and outcomes research, analytics, customer service and billing operations. Additionally, she spent several years as a laboratory researcher at the University of Pittsburgh Medical Center researching migraine, epilepsy, and ALS. Robin holds a B.S. in Molecular Biology from the University of Pittsburgh, and an M.B.A. in Finance from the Joseph M. Katz Graduate School of Business from the University of Pittsburgh.